Skip to main content
. 2022 Mar 1;13:852215. doi: 10.3389/fimmu.2022.852215

Table 1.

Anti-IgLON5 neuropathological diagnostic criteria.

Level of certainty Neuropathological findings CSF/serum Anti-IgLON5 antibodies Clinical history HLA-DRB1*10:01 HLA- DQB1*05:01
Definite + + +/- +/-
Probable + No information +/- +/-
Possible + No information No information No information